Rhythm Pharmaceuticals, Inc.
RYTM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6,498,362 | $4,024,215 | $3,340,235 | $3,448,144 |
| - Cash | $52,078 | $135,586 | $106,095 | $89,137 |
| + Debt | $151,005 | $4,191 | $4,063 | $3,938 |
| Enterprise Value | $6,597,289 | $3,892,820 | $3,238,203 | $3,362,945 |
| Revenue | $51,298 | $48,502 | $32,704 | $41,830 |
| % Growth | 5.8% | 48.3% | -21.8% | – |
| Gross Profit | $45,799 | $42,959 | $29,056 | $38,043 |
| % Margin | 89.3% | 88.6% | 88.8% | 90.9% |
| EBITDA | -$47,747 | -$40,099 | -$43,626 | -$37,552 |
| % Margin | -93.1% | -82.7% | -133.4% | -89.8% |
| Net Income | -$52,904 | -$46,632 | -$49,498 | -$43,292 |
| % Margin | -103.1% | -96.1% | -151.4% | -103.5% |
| EPS Diluted | -0.82 | -0.75 | -0.81 | -0.72 |
| % Growth | -9.3% | 7.4% | -12.5% | – |
| Operating Cash Flow | -$26,622 | -$23,313 | -$40,351 | -$18,845 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$26,622 | -$23,313 | -$40,351 | -$18,845 |